ProgenaCare
Tom Barrows is an experienced scientific leader with a comprehensive background in research and product development. Currently serving as Chief Scientific Adviser at ProgenaCare Global since September 2021, Tom has held significant roles including Executive Vice President and Chief Scientific Officer at Cell Constructs, Inc. since July 2008, and Director of Product Development at Aderans Research Institute from 2002 to 2008. Previous positions include Vice President at BioAmide, Inc., Principal Scientist at Focal, and Senior Research Specialist at 3M for over two decades. Tom Barrows holds a Ph.D. in Organic Chemistry from Penn State University, obtained in 1974.
This person is not in any teams
ProgenaCare
ProgenaCare Global™ is healing wound care. We are a purpose-driven medical device company leveraging cutting-edge advances in biomaterials to provide effective, affordable advanced wound care solutions to patients across the socioeconomic spectrum and around the world. After more than a decade of research and development, ProgenaCare Global is commercializing ProgenaMatrix®, the first product built on our proprietary human keratin platform. ProgenaMatrix is the only commercially available human keratin matrix for wound care. Due to its unique keratin technology, ProgenaMatrix is capable of providing excellent outcomes for patients with complex wounds in a highly cost-effective manner.